BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9052853)

  • 1. Failure of insulin-like growth factor 1 to improve radiocontrast nephropathy.
    Fuchs S; Yaffe R; Beeri R; Rosen S; Heyman SN; Brezis M
    Exp Nephrol; 1997; 5(1):88-94. PubMed ID: 9052853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure.
    Ding H; Kopple JD; Cohen A; Hirschberg R
    J Clin Invest; 1993 May; 91(5):2281-7. PubMed ID: 8486787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-I increases p21 expression and attenuates cisplatin-induced acute renal injury in rats.
    Yasuda H; Kato A; Miyaji T; Zhou H; Togawa A; Hishida A
    Clin Exp Nephrol; 2004 Mar; 8(1):27-35. PubMed ID: 15067513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-I ameliorates transient ischemia-induced acute renal failure in rats.
    Noguchi S; Kashihara Y; Ikegami Y; Morimoto K; Miyamoto M; Nakao K
    J Pharmacol Exp Ther; 1993 Nov; 267(2):919-26. PubMed ID: 8246168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endogenous insulin-like growth factor system in radiocontrast nephropathy.
    Symon Z; Fuchs S; Agmon Y; Weiss O; Nephesh I; Moshe R; Brezis M; Flyvbjerg A; Raz I
    Am J Physiol; 1998 Mar; 274(3):F490-7. PubMed ID: 9530265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor 1 and endotoxin-mediated kidney dysfunction in critically ill, parenterally fed rats.
    Manzo CB; Dickerson RN; Settle RG; Rajter JJ
    Nutrition; 1993; 9(6):528-31. PubMed ID: 8111143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat.
    Agmon Y; Peleg H; Greenfeld Z; Rosen S; Brezis M
    J Clin Invest; 1994 Sep; 94(3):1069-75. PubMed ID: 8083347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal microcirculation and tissue damage during acute ureteral obstruction in the rat: effect of saline infusion, indomethacin and radiocontrast.
    Heyman SN; Fuchs S; Jaffe R; Shina A; Ellezian L; Brezis M; Rosen S
    Kidney Int; 1997 Mar; 51(3):653-63. PubMed ID: 9067896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor I administration in young rats with acute renal failure.
    Medina A; Fernández-Fuente M; Carbajo-Pérez E; Santos F; Amil B; Rodríguez J; Crespo M
    Pediatr Nephrol; 2002 Dec; 17(12):1005-12. PubMed ID: 12478349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar cardiovascular effects of growth hormone and insulin-like growth factor-I in rats after experimental myocardial infarction.
    Tivesten A; Caidahl K; Kujacic V; Sun XY; Hedner T; Bengtsson BA; Isgaard J
    Growth Horm IGF Res; 2001 Jun; 11(3):187-95. PubMed ID: 11735233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of amino acid solution and recombinant human growth hormone on growth hormone/insulin like growth factor-1 axis in rats with liver cirrhosis].
    Liang LJ; Luo SM; Hu WJ
    Zhonghua Wai Ke Za Zhi; 2005 Jun; 43(11):697-701. PubMed ID: 16008955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of IGF-I on the glomerular filtration rate in non-diabetic patients with advanced chronic kidney disease.
    Kuan Y; Surman J; Frystyk J; El Nahas AM; Flyvbjerg A; Haylor JL
    Growth Horm IGF Res; 2009 Jun; 19(3):219-25. PubMed ID: 19046909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of insulin-like growth factor-I (IGF-I) in the treatment of acute renal insufficiency].
    Bohé J; Fouque D
    Nephrologie; 1998; 19(1):11-3. PubMed ID: 9551446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of L-arginine on the expression of insulin-like growth factors and insulin-like growth factor binding protein 3 in rats with intrauterine growth retardation].
    Lu Y; Liu XM; Li SQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):319-22. PubMed ID: 16923367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a novel model for investigation of radiocontrast nephrotoxicity.
    Harmon RC; Duffy SP; Terneus MV; Ball JG; Valentovic MA
    Nephrol Dial Transplant; 2009 Mar; 24(3):763-8. PubMed ID: 18840895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in intrarenal oxygenation as evaluated by BOLD MRI in a rat kidney model for radiocontrast nephropathy.
    Prasad PV; Priatna A; Spokes K; Epstein FH
    J Magn Reson Imaging; 2001 May; 13(5):744-7. PubMed ID: 11329196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-I and analogues increase growth in artificially-reared neonatal pigs.
    Dunshea FR; Chung CS; Owens PC; Ballard JF; Walton PE
    Br J Nutr; 2002 Jun; 87(6):587-93. PubMed ID: 12067429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine-1 receptor agonist: renal effects and its potential role in the management of radiocontrast-induced nephropathy.
    Asif A; Epstein DL; Epstein M
    J Clin Pharmacol; 2004 Dec; 44(12):1342-51. PubMed ID: 15545304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-specific regulation of IGF-I and IGF-binding proteins in response to TNFalpha.
    Lang CH; Nystrom GJ; Frost RA
    Growth Horm IGF Res; 2001 Aug; 11(4):250-60. PubMed ID: 11735242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral elevation of IGF-1 fails to alter Abeta clearance in multiple in vivo models.
    Lanz TA; Salatto CT; Semproni AR; Marconi M; Brown TM; Richter KE; Schmidt K; Nelson FR; Schachter JB
    Biochem Pharmacol; 2008 Mar; 75(5):1093-103. PubMed ID: 18076866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.